- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Astellas Pharma Canada, Inc.
Total 1238 results
-
OSI PharmaceuticalsCompletedAdvanced Pancreatic CancerUnited States
-
OSI PharmaceuticalsCompletedAdvanced Non Small Cell Lung Cancer | Failed Prior ChemotherapyUnited States
-
Tufts UniversityAstellas Pharma IncCompletedMobility Limitation
-
Heidelberg UniversityAstellas Pharma IncUnknownLiver Graft DysfunctionGermany
-
Astellas Pharma IncSchering-PloughCompleted
-
Mayo ClinicAstellas Pharma IncCompletedCoronary Artery DiseaseUnited States
-
Northwestern UniversityAstellas Pharma IncTerminatedA Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant RecipientsTransplant; Failure, KidneyUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Astellas Pharma IncBasilea PharmaceuticaCompletedHealthy Volunteers | Pharmacokinetics of Isavuconazole | Pharmacokinetics of MidazolamUnited States
-
University of British ColumbiaSimon Fraser University; Astellas Pharma Canada, Inc.CompletedRenal Transplant | Renal DiseaseCanada
-
Lawson Health Research InstituteNovartis; Canadian Institutes of Health Research (CIHR); Astellas Pharma Canada...Completed
-
Ogeda S.A.Completed
-
Ophthotech CorporationTerminatedAge-related Macular DegenerationUnited States
-
Ophthotech CorporationTerminatedAge-Related Macular DegenerationItaly, Canada, Switzerland, United States, United Kingdom, Austria, Belgium, Brazil, Czechia, Estonia, Latvia, Poland, Slovakia
-
FibroGenAstraZeneca; Astellas Pharma IncCompletedAnemia | End Stage Renal DiseaseUnited States
-
FibroGenAstraZeneca; Astellas Pharma IncCompletedAnemia | End Stage Renal Disease | Chronic Kidney DiseasePuerto Rico, United States
-
Loyola UniversityAstellas Pharma IncCompletedOveractive Bladder SyndromeUnited States
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
Hartford HospitalAstellas Pharma IncCompletedMyocardial Ischemia | Coronary Artery DiseaseUnited States
-
OSI PharmaceuticalsCompleted
-
OSI PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States, United Kingdom
-
OSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompletedSCLC | Carcinoma, Small CellUnited Kingdom, United States
-
Astellas Pharma IncOSI PharmaceuticalsCompletedOvarian NeoplasmsUnited Kingdom, United States
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
Astellas Institute for Regenerative MedicineCompleted
-
Astellas Institute for Regenerative MedicineCompleted
-
Astellas Institute for Regenerative MedicineCompletedAge-Related Macular DegenerationUnited States
-
Astellas Institute for Regenerative MedicineRecruiting
-
Astellas Institute for Regenerative MedicineEnrolling by invitationMacular Degenerative DiseaseUnited Kingdom, United States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingUrothelial CancerUnited States, Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Thailand and more
-
Astellas Pharma IncSeagen Inc.; Agensys, Inc.CompletedNeoplasms | Tumors | Medical OncologyUnited States, Canada
-
Astellas Institute for Regenerative MedicineCompletedDry Age Related Macular DegenerationUnited States
-
Astellas Institute for Regenerative MedicineCompletedStargardt's Macular DystrophyUnited States
-
Astellas Institute for Regenerative MedicineCompletedStargardt's Macular DystrophyUnited States
-
Astellas Institute for Regenerative MedicineWithdrawnAge-Related Macular DegenerationUnited States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.Active, not recruitingUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Italy, Spain, Canada, France, Puerto Rico
-
Astellas Pharma Europe Ltd.Merck Sharp & Dohme LLCCompletedClostridium DifficileGreece, Spain, Russian Federation, Denmark, Austria, Belgium, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Poland, Portugal, Romania, Slovenia, Sweden, Switzerland, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.IRCCS, Ospedale Pediatrico Bambino GesuCompletedCandidiasis, Systemic | Candida MeningitisItaly
-
Astellas Pharma Europe B.V.Merck Sharp & Dohme LLCCompletedClostridium Difficile-associated Diarrhea (CDAD)United States, Belgium, Italy, Canada, France, Germany, Hungary, Poland, Romania, Spain
-
RTOG Foundation, Inc.Pfizer; Astellas Pharma IncActive, not recruitingProstate CancerUnited States, Canada
-
Duke UniversityAstellas Pharma Inc; Medivation, Inc.CompletedProstate CancerUnited States
-
Rabin Medical CenterAstellas Pharma Inc; Teva PharmaUnknownMedication AdherenceIsrael
-
Astellas Pharma Global Development, Inc.National Institute on Drug Abuse (NIDA)Completed
-
Astellas Pharma Global Development, Inc.National Institute on Drug Abuse (NIDA)Completed